Bright Minds Biosciences Inc (DRUG)

11:44 AM

What analysts say about Bright Minds Biosciences Inc. stockConsistently superior profits - Jammu Links News

11:44 AM

08:15 AM

What drives TTAM stock priceHigh-yield investments - Jammu Links News

08:15 AM

07:49 AM

What drives Bright Minds Biosciences Inc. stock priceOutstanding risk-reward balance - Jammu Links News

07:49 AM

01:50 AM

Can Bright Minds Biosciences Inc. stock recover from recent declineFree Expert-Led Investment Training - Newser

01:50 AM

12:47 PM

Does Bright Minds Biosciences Inc. stock pay reliable dividendsSmall Risk Large Return Trades - newser.com

12:47 PM

Jul 16, 2025

Why Bright Minds Biosciences Inc. stock attracts strong analyst attentionTop Performer Shortlist - Newser

Jul 16, 2025

Jul 15, 2025

How Bright Minds Biosciences Inc. stock performs during market volatilityFree Trading Group - Newser

Jul 15, 2025

Jul 15, 2025

What makes Bright Minds Biosciences Inc. stock price move sharplyRisk Controlled Trading Ideas - newser.com

Jul 15, 2025

Jul 15, 2025

Why TBCH stock attracts strong analyst attentionTop Momentum Stock Pick - Newser

Jul 15, 2025

Jul 11, 2025

How To Trade (DRUG) - news.stocktradersdaily.com

Jul 11, 2025

Jul 05, 2025

Cantor Fitzgerald Forecasts DRUG FY2025 Earnings - Defense World

Jul 05, 2025

Jun 26, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 26, 2025

Jun 16, 2025

4,793 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025

Jun 12, 2025

DRUG FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World

Jun 12, 2025

Jun 06, 2025

Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World

Jun 06, 2025

Jun 05, 2025

6,600 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Jane Street Group LLC - Defense World

Jun 05, 2025

Jun 04, 2025

40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLC - Defense World

Jun 04, 2025

Jun 01, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 01, 2025

May 28, 2025

(DRUG) Investment Analysis and Advice - news.stocktradersdaily.com

May 28, 2025

May 28, 2025

Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 28, 2025

May 28, 2025

Bright Minds Showcases Revolutionary CNS Drug Portfolio at Major Jefferies Healthcare Conference - Stock Titan

May 28, 2025

May 26, 2025

HC Wainwright Issues Pessimistic Outlook for DRUG Earnings - Defense World

May 26, 2025

May 26, 2025

What is Chardan Capital’s Forecast for DRUG FY2025 Earnings? - Defense World

May 26, 2025

May 23, 2025

Chardan Capital Reiterates “Buy” Rating for Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

May 23, 2025

May 21, 2025

Bright Minds Biosciences (DRUG) Receives Consistent 'Buy' Rating from Chardan Capital | DRUG Stock News - GuruFocus

May 21, 2025

May 20, 2025

Bright Minds (DRUG) Schedules Virtual R&D Day to Discuss Epileps - GuruFocus

May 20, 2025

May 20, 2025

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025 - The Manila Times

May 20, 2025

May 20, 2025

Top Neurologists Reveal Latest Absence Epilepsy Breakthrough: Bright Minds Showcases Phase 2 Trial Progress - Stock Titan

May 20, 2025

May 18, 2025

FY2025 Earnings Forecast for DRUG Issued By Chardan Capital - Defense World

May 18, 2025

May 16, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025

May 14, 2025

Bright Minds Biosciences (DRUG) to Release Earnings on Wednesday - Defense World

May 14, 2025

May 13, 2025

TD Cowen Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy Recommendation - Nasdaq

May 13, 2025

May 13, 2025

Bright Minds stock rating initiated with Buy at TD Cowen - Investing.com Australia

May 13, 2025

May 13, 2025

TD Cowen Initiates Coverage on Bright Minds Biosciences (DRUG) w - GuruFocus

May 13, 2025

May 13, 2025

Bright Minds stock rating initiated with Buy at TD Cowen By Investing.com - Investing.com Nigeria

May 13, 2025

May 13, 2025

Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy - marketscreener.com

May 13, 2025

May 13, 2025

Bright Minds (DRUG) Reports Promising Results in Epilepsy Research | DRUG Stock News - GuruFocus

May 13, 2025

May 13, 2025

Bright Minds reports BMB-101 eliminates drop attacks in mice By Investing.com - Investing.com Nigeria

May 13, 2025

May 13, 2025

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101 - The Manila Times

May 13, 2025

May 13, 2025

Bright Minds (DRUG) Gains 'Buy' Rating from TD Cowen Analyst | D - GuruFocus

May 13, 2025

May 10, 2025

Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $83.25 - Defense World

May 10, 2025

May 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Chardan Capital - Defense World

May 10, 2025

May 08, 2025

Chardan Capital Initiates a Buy Rating on Bright Minds Biosciences (DRUG) - The Globe and Mail

May 08, 2025

May 07, 2025

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside - Benzinga

May 07, 2025

May 07, 2025

(DRUG) On The My Stocks Page - news.stocktradersdaily.com

May 07, 2025

May 07, 2025

Chardan Capital Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy Recommendation - Nasdaq

May 07, 2025